Neil Johnson, executive director of the Global Heart Hub (c/o Novartis)
October 7, 2022 02:40 PM EDT
Pharma
Marketing

No­var­tis shoots 'From the Heart' in new video se­ries to spur dis­cus­sions — and changes — in car­dio­vas­cu­lar dis­ease

Beth Snyder Bulik

Senior Editor

No­var­tis wants to get peo­ple talk­ing — about car­dio­vas­cu­lar dis­ease. Its new “From the Heart” video se­ries talks to re­searchers, pa­tients, pub­lic health of­fi­cials and ad­vo­cates …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times